PR firm gives up marijuana

New York-based communications consultancy 5WPR has removed Creative Edge Nutrition, a Michigan-based firm seeking a licence to produce medical marijuana, from its client list.

According to Canadian newspaper the Globe and Mail, the falling-out happened after Creative Edge issued press releases under 5WPR’s name ‘without its knowledge or approval.’ The first controversial press release featured a discussion between a shareholder and Creative Edge’s ‘internal public relations’. A second one announced the appointment of a new CEO for the firm. Both releases were reissued 10 days later, with 5WPR’s name removed.

The newspaper had earlier revealed there were ‘mounting concerns’ over Creative Edge’s recent conduct, with former CEO Bill Chaaban allegedly netting $4.6 mn from the massive sale of his stock in the past year. It was also reported that Creative Edge, which operates a Canadian branch called CEN Biotech, had given out premature, ‘misleading’ information about its ongoing application with Health Canada to open ‘the world’s largest’ marijuana plant in Lakeshore, Ontario.

Denying these allegations in a press release, the firm also stated it could not comment further or accept a formal interview as it was under the quiet period restrictions normally required for SEC-reporting companies, even though Creative Edge trades on the OTC market. Its share price has fallen sharply since the Globe’s article, bringing its market capitalization down to $42 mn from its $350 mn peak.

Creative Edge is one of many examples of marijuana-focused penny stocks that reached spectacular heights despite having no proper revenue. Companies such as Tweed Marijuana and OrganiGram, which were granted one of the 15 Canadian licenses to produce medical marijuana, saw their stock price skyrocket after listing last year. Both companies’ shares slowly declined over the following months.

The ‘pot stock’ frenzy in North America seems unlikely to fade, however, with Canadian mining exploration companies, frustrated by tepid investor interest, reportedly rapidly transitioning into marijuana businesses.

Upcoming events

  • Briefing – Lessons from the 2025 Proxy Season
    Tuesday, July 22, 2025

    Briefing – Lessons from the 2025 Proxy Season

    In partnership with WHEN 8.00 am PT / 11.00 am ET / 4.00 pm BST / 5.00 pm CET DURATION 45 minutes About the event The 2025 proxy season was influenced by several key issues, including changes announced in Staff Legal Bulletin 14M regarding the interpretation of Rule 14a-8, and…

    Online
  • Briefing – Effective earnings preparation amid macro volatility
    Thursday, August 07, 2025

    Briefing – Effective earnings preparation amid macro volatility

    In partnership with WHEN 8.00 am PT / 11.00 am ET / 4.00 pm BST / 5.00 pm CET DURATION 45 minutes About the event Amid constant tariff news, geopolitical upheaval and other developments stemming from the new US administration, IR teams have their work cut out as they prepare…

    Online
  • IR Impact Forum – AI & Technology
    Wednesday, November 12, 2025

    IR Impact Forum – AI & Technology

    About the event As more investors and corporate communication teams embrace AI, machine learning and emerging technologies to inform their decision-making, investor relations professionals are facing a pivotal moment: adapt and lead, or risk falling behind. At this early but fast-moving stage of adoption, IR teams are asking important questions…

    New York, US

Explore

Andy White, Freelance WordPress Developer London